Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | ESR1 | P03372 | 3/20 | 0.56 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | ORAI1 | Q96D31 | 1/20 | 0.41 |
| ▸ | ORAI2 | Q96SN7 | 1/20 | 0.41 |
| ▸ | ORAI3 | Q9BRQ5 | 1/20 | 0.41 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 2/20 | 0.39 |
| ▸ | G6PD | P11413 | 1/20 | 0.39 |
| ▸ | IDO1 | P14902 | 2/20 | 0.37 |
| ▸ | TDO2 | P48775 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2454269 | 1.00 | CYP3A4 (0.67) | CYP3A4TDP1ESR1ESR2TSHR | |
| SCHEMBL11837589 | 0.97 | CYP3A4 (0.63) | CYP3A4TDP1ESR1ESR2TSHR | |
| 1,4-Dichlorobenzene SCHEMBL11803922 | 0.97 | CYP3A4 (0.71) | CYP3A4TDP1ESR1ESR2TSHR | |
| Chlorobenzene SCHEMBL7171696 | 0.89 | CYP3A4 (0.67) | CYP3A4TDP1ESR1ESR2TSHR | |
| SCHEMBL152775 | 0.88 | LMNA (0.57) | CYP3A4TDP1ESR1ESR2TSHR | |
| SCHEMBL31325559 | 0.85 | LMNA (0.53) | CYP3A4TDP1ESR1ESR2TSHR | |
| SCHEMBL11551608 | 0.85 | LMNA (0.53) | CYP3A4TDP1ESR1ESR2TSHR | |
| Bromide SCHEMBL28414241 | 0.85 | LMNA (0.53) | CYP3A4TDP1ESR1ESR2TSHR | |
| SCHEMBL16094788 | 0.85 | TDP1 (0.92) | CYP3A4TDP1ESR1ESR2TSHR | |
| SCHEMBL1301471 | 0.85 | TDP1 (0.92) | CYP3A4TDP1ESR1ESR2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250188007-A1 | PRODUCTION METHOD OF 2,7-OCTADIEN-1-OL | KURARAY CO., LTD. (JP) | 2025-06-12 | — | — | US | disclosed |
| EP-4484401-A1 | PRODUCTION METHOD OF 2,7-OCTADIEN-1-OL | Kuraray Co., Ltd. (JP) | 2025-01-01 | — | — | EP | disclosed |
| US-20240002313-A1 | [11C]-LABELED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME | NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY (JP) | 2024-01-04 | — | — | US | disclosed |
| CN-117098749-A | [11C] Labeled acyclic retinoids, central nervous system activators and methods for their manufacture | 国立研究开发法人国立长寿医疗研究中心 | 2023-11-21 | — | — | CN | disclosed |
| EP-4249058-A1 | [11C]-LABELLED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME | National Center for Geriatrics and Gerontology (JP) | 2023-09-27 | — | — | EP | disclosed |
| WO-2023162973-A1 | PRODUCTION METHOD OF 2,7-OCTADIEN-1-OL | 株式会社クラレ | 2023-08-31 | — | — | WO | disclosed |
| CN-115055207-B | Method for preparing aryl phosphine by reducing aryl phosphine oxide | 清华大学 | 2023-07-21 | — | — | CN | disclosed |
| WO-2023113576-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-06-22 | — | — | WO | disclosed |
| EP-3586961-B1 | METHOD FOR MANUFACTURING CATALYST LIQUID | KURARAY CO (JP) | 2023-06-07 | — | — | EP | disclosed |
| US-11628430-B2 | Method for manufacturing catalyst liquid | KURARAY CO., LTD. (JP) | 2023-04-18 | — | — | US | disclosed |
| US-4593128-A | Using a di- or triphenylphosphine compound | ATLANTIC RICHFIELD COMPANY (US) | 1986-06-03 | — | — | US | disclosed |
| EP-0174174-A2 | A method of stabilising hydroxy-containing polymers of butadiene or substituted derivatives thereof | ELF ATOCHEM S.A. (FR) | 1986-03-12 | — | — | EP | disclosed |
| US-4480137-A | ALDEHYDES FROM ALPHA-OLEFINS; HEAT RESISTANCE; CATALYST SELECTIVITY | EXXON RESEARCH & ENGINEERING COMPANY (US) | 1984-10-30 | — | — | US | disclosed |
| US-4454353-A | Trihydrocarbyl silyl substituted alkyl diaryl phosphine transition metal complexes and their use as homogeneous hydroformylation-aldolization catalysts | EXXON RESEARCH AND ENGINEERING CO. (US) | 1984-06-12 | — | — | US | disclosed |
| US-4451673-A | REACTING OLEFINS WITH CARBON MONOXIDE AND HYDROGEN TO YIELD ALDEHYDES | EXXON RESEARCH AND ENGINEERING CO. (US) | 1984-05-29 | — | — | US | disclosed |
| US-4450299-A | ALDEHYDES FROM UNSATURATED ACYCLIC HYDROCARBONS, CARBON MONOXIDE AND HYDROGEN | EXXON RESEARCH AND ENGINEERING CO. (US) | 1984-05-22 | — | — | US | disclosed |
| US-4257973-A | USING ORGANOPHOSPHORUS-PALLADIUM HALIDE COORDINATION CATALYST | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-03-24 | — | — | US | disclosed |
| US-3992456-A | BY REACTING BUTADIENE WITH WATER IN THE PRESENCE OF A PALLADIUM CATALYST | UNION CARBIDE CORPORATION (US) | 1976-11-16 | — | — | US | disclosed |
| US-3987009-A | TRANSITION METAL CATALYST COMPOSITIONS | UNION CARBIDE CORPORATION (US) | 1976-10-19 | — | — | US | disclosed |
| US-3972928-A | Regulating plant growth with quaternary phosphonium aliphatic carboxamide salts | BAYCHEM CORPORATION (US) | 1976-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240002313-A1 | [11C]-LABELED ACYCLIC RETINOID, CENTRAL NERVOUS SYSTEM ACTIVATOR, AND PRODUCTION METHODS FOR SAME | NR2E3, FABP7, RARB | CYP3A4 2009/4885TDP1 3661/4885ESR1 1588/4885 |
| US-11628430-B2 | Method for manufacturing catalyst liquid | OSGEP, PNP, ALK | CYP3A4 297/4885TDP1 3301/4885ESR1 2856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.